NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Thrombocytopenia due to chronic liver disease
Date of first enrollment	30/08/2012
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : S-888711 INN of investigational material : Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Efficacy, safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Main inclusion criteria: Thrombocytopenic patients with chronic liver disease undergoing percutaneous ablation.
Exclude criteria	Main exclusion criteria: Patients who received blood transfusions (except for red blood cell products and albumin preparations) within 14 days prior to enrollment. Patients who previously received TPO receptor agonists.